Sai Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/04/2026 ,inter alia, to consider and approve INTIMATION OF BOARD MEETING ....
SAIPARENT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sai Parenterals Ltd has informed the exchanges that a Board Meeting is scheduled for April 20, 2026 to consider and approve a proposal to invest in or lend to Noumed Pharmaceuticals Pty Limited, Australia. This entity is a step-down subsidiary of the company, with the investment to be routed through Sai Parenterals PTE Limited, a wholly owned subsidiary. The investment is subject to necessary regulatory and legal approvals. This is a routine prior intimation under SEBI Listing Regulations, and no further specifics on the investment amount were disclosed.
The proposed investment in a step-down subsidiary signals ongoing capital commitment to group entities, which could impact cash flow. However, the lack of specifics makes the direct stock impact unclear at this stage.